A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Epoprostenol
Potassium guaiacolsulfonate
The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Temocapril.
Epoprostenol
Potassium gluconate
The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Temocapril.
Epoprostenol
Potassium hydroxide
The risk or severity of hyperkalemia can be increased when Potassium hydroxide is combined with Temocapril.
Epoprostenol
Potassium bitartrate
The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Temocapril.
Epoprostenol
Potassium bicarbonate
The risk or severity of hyperkalemia can be increased when Potassium bicarbonate is combined with Temocapril.
Epoprostenol
Potassium nitrate
The risk or severity of hyperkalemia can be increased when Potassium nitrate is combined with Temocapril.
Epoprostenol
Potassium lactate
The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Temocapril.
Epoprostenol
Potassium perchlorate
The risk or severity of hyperkalemia can be increased when Potassium perchlorate is combined with Temocapril.
Epoprostenol
Dipotassium phosphate
The risk or severity of hyperkalemia can be increased when Dipotassium phosphate is combined with Temocapril.
Epoprostenol
Monopotassium phosphate
The risk or severity of hyperkalemia can be increased when Monopotassium phosphate is combined with Temocapril.
Epoprostenol
Potassium citrate
The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Temocapril.
Epoprostenol
Potassium alum
The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Temocapril.
Epoprostenol
Potassium Iodide
The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Temocapril.
Epoprostenol
Canrenone
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Canrenone.
Epoprostenol
Canrenoic acid
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Canrenoic acid.
Epoprostenol
Azosemide
Azosemide may increase the hypotensive activities of Temocapril.
Epoprostenol
Piretanide
Piretanide may increase the hypotensive activities of Temocapril.
Epoprostenol
Thiosalicylic acid
The risk or severity of renal failure can be increased when Thiosalicylic acid is combined with Temocapril.
Epoprostenol
Choline salicylate
The risk or severity of renal failure can be increased when Choline salicylate is combined with Temocapril.
Epoprostenol
Aloxiprin
The risk or severity of renal failure can be increased when Aloxiprin is combined with Temocapril.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3